2025-522523-96-00招募中1 期
A First-in-Human Study of KK2223 in Participants with T-cell Non-Hodgkin Lymphoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 入组人数
- 34
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
Corporate Communications
Scientific
Kyowa Kirin Inc.
研究点 (8)
Loading locations...
相似试验
招募中
1 期
First in human, Phase 1a/1b Study of KM-023 in healthy volunteers and Olmsted syndrome patients2025-521446-20-00Kamari Pharma Ltd.64
招募中
1 期
A clinical trial of MK-7228 in adults (MK-7228-002)Atherosclerosis2025-522147-18-00Merck Sharp & Dohme LLC40
已完成
1 期
Study of KITE-222 in Participants With Relapsed/Refractory Acute Myeloid LeukemiaAcute Myeloid Leukemia2023-507748-35-00Kite Pharma Inc.10
招募中
1 期
A Phase 1, First-in-Human Study of MEN2312, a KAT6 inhibitor, as Monotherapy and in Combination in Participants with Advanced Breast Cancer2024-514661-19-01Stemline Therapeutics Inc.46
已完成
1 期
A clinical study of MK-2828 in healthy people (MK-2828-001)Atherosclerosis2024-513377-51-00Merck Sharp & Dohme LLC16